The Search for NASH Treatments: Drug Pipeline, Market Growth, and Research Trends
Nonalcoholic Steatohepatitis (NASH) is a progressive liver disease marked by inflammation, hepatocellular damage, and fibrosis. It represents the more severe form of Non-Alcoholic Fatty Liver Disease (NAFLD) and affects millions worldwide. Currently, there are no FDA-approved therapies for NASH, making it a major focus of clinical research and drug development. Understanding NASH and Its...
0 Comments 0 Shares 2K Views 0 Reviews